Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01833351 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Intravenous Ascorbic Acid
A Phase 1 study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT01833351 is a Phase 1 study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 34 participants.
The verdict
NCT01833351, a Phase 1 study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
This Phase I study will be conducted in 2 parts to examine safety and pharmacokinetics of escalating doses of intravenous ascorbic acid (AA) first in healthy volunteers followed by evaluation in oncology subjects. The study will be conducted in the Program in Integrative Medicine Infusion Clinic at the University of Kansas Medical Center in conjunction with the Program in Integrative Medicine, Kansas Cancer Research Institute, Department of Pharmacy, Department of Medical Oncology, the Division of Surgical Oncology,and with consultants from the NIH, and FDA.
Interventions
- DRUG IV Vitamin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2011-05 |
| Est. Completion | 2015-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01833351
The ClinicalTrials.gov registry entry for NCT01833351 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IV Vitamin C is the first listed.
NCT01833351 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01833351 about?
NCT01833351 is a clinical study titled "Evaluation of Intravenous Ascorbic Acid". This Phase I study will be conducted in 2 parts to examine safety and pharmacokinetics of escalating doses of intravenous ascorbic acid (AA) first in healthy volunteers followed by evaluation in oncology subjects. The study will be conducted in the Program in Integrative Medicine Infusion Clinic at ...
What is the current status of trial NCT01833351?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2011-05. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01833351?
The interventions under investigation include: IV Vitamin C (DRUG).
Who is sponsoring clinical trial NCT01833351?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.